What is the first line of treatment for hemiplegic migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Hemiplegic Migraines

NSAIDs (such as acetylsalicylic acid, ibuprofen, or diclofenac potassium) are the first-line treatment for hemiplegic migraines. 1

Understanding Hemiplegic Migraine

Hemiplegic migraine is a rare subtype of migraine with aura characterized by temporary motor weakness (hemiparesis) during attacks, which may be accompanied by visual, sensory, or speech disturbances. It can occur in two forms:

  • Familial hemiplegic migraine (FHM): With autosomal dominant inheritance
  • Sporadic hemiplegic migraine (SHM): Without family history

The motor symptoms typically last less than 72 hours and are associated with other aura symptoms 2.

Treatment Algorithm for Hemiplegic Migraines

Acute Treatment

  1. First-line: NSAIDs

    • Options include acetylsalicylic acid, ibuprofen, naproxen sodium, or diclofenac potassium 1
    • Acetaminophen alone is ineffective 1
    • The acetaminophen-aspirin-caffeine combination can also be effective 1
  2. For nausea/vomiting

    • Use prokinetic antiemetics (domperidone or metoclopramide) as adjuncts 1
    • Consider non-oral routes of administration when nausea/vomiting are significant 1
  3. Second-line options (controversial)

    • While triptans are traditionally contraindicated in hemiplegic migraine according to some guidelines 1, more recent evidence suggests they may be safe and effective for most hemiplegic migraine patients 3
    • Dihydroergotamine (DHE) intranasal may be considered in some cases 1
  4. Rescue medications

    • When other treatments fail, opioids may be considered if risk of abuse has been addressed 1

Important Cautions

  • Avoid oral ergot alkaloids, which are poorly effective and potentially toxic 1
  • Avoid opioids and barbiturates as regular treatment due to questionable efficacy and risk of dependency 1
  • Limit acute treatments to no more than twice weekly to prevent medication overuse headache 1

Preventive Treatment

Consider preventive treatment when:

  • Two or more migraine attacks per month with disability for ≥3 days per month
  • Use of rescue medication more than twice weekly
  • Failure of or contraindications to acute treatments
  • Presence of hemiplegic migraine 1

Preventive Options for Hemiplegic Migraine

First-line preventive agents:

  • Sodium valproate/divalproex sodium (500-1,500 mg/day)
  • Amitriptyline (30-150 mg/day)
  • Flunarizine (where available)
  • Lamotrigine
  • Verapamil
  • Acetazolamide 4

Second-line options:

  • Topiramate
  • Candesartan
  • Pizotifen 4

Note on beta-blockers: While propranolol and timolol are first-line for typical migraine, their use in hemiplegic migraine is more controversial, though evidence of adverse effects is insufficient to absolutely contraindicate them 4.

Monitoring and Follow-up

  • Evaluate treatment efficacy after 2-3 months for oral preventives 1
  • Preventive medications must be given at therapeutic doses for at least 6-8 weeks before judging ineffectiveness 5
  • Consider pausing preventive treatment after 6-12 months of successful control 1

Special Considerations

  • Patients with hemiplegic migraine may require hospitalization for long-lasting auras 2
  • Genetic testing can confirm but not rule out the diagnosis, as some genes remain unidentified 4
  • Conventional cerebral angiography is contraindicated in hemiplegic migraine as it may provoke an attack 4

By following this treatment approach, the goal is to reduce the frequency, duration, and severity of hemiplegic migraine attacks while minimizing adverse effects and improving quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnostic and therapeutic aspects of hemiplegic migraine.

Journal of neurology, neurosurgery, and psychiatry, 2020

Research

Treatment of hemiplegic migraine with triptans.

European journal of neurology, 2007

Research

Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Current treatment options in neurology, 2013

Research

The acute and preventative treatment of episodic migraine.

Annals of Indian Academy of Neurology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.